Anika Therapeutics diskutieren
Anika Therapeutics
WKN: 889120 / Symbol: ANIK / Name: Anika / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
13,30 €
4,72 %
Anika Therapeutics, Inc. (NASDAQ: ANIK) was upgraded by analysts at Barrington Research from a "market perform" rating to an "outperform" rating.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $24.00 to $28.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $28.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $37.00 to $25.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $25.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) is now covered by analysts at B. Riley. They set a "buy" rating and a $21.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $20.00 to $19.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $19.00 to $15.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics (NASDAQ:ANIK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $15.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics (NASDAQ:ANIK) had its price target raised by analysts at Barrington Research from $15.00 to $16.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics (ANIK) had its price target raised by Barrington Research from $16.00 to $17.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics (ANIK) had its "buy" rating reaffirmed by B. Riley Financial, Inc..
Ratings data for ANIK provided by MarketBeat
Neueste Beiträge
Needham___Company_LL in Silicon Motion Technology Corp. ADR diskutieren